A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myeloma

por Becker, P S, Gooley, T A, Green, D J, Burwick, N, Kim, T Y, Kojouri, K, Inoue, Y, Moore, D J, Nelli, E, Dennie, T, Bensinger, W I
Publicado 2016